168 related articles for article (PubMed ID: 28966621)
1. New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells.
Negera E; Bobosha K; Walker SL; Endale B; Howe R; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2017; 8():1149. PubMed ID: 28966621
[TBL] [Abstract][Full Text] [Related]
2. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
[TBL] [Abstract][Full Text] [Related]
3. T-cell regulation in Erythema Nodosum Leprosum.
Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
[TBL] [Abstract][Full Text] [Related]
6. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
[TBL] [Abstract][Full Text] [Related]
7. Complement C1q expression in Erythema nodosum leprosum.
Negera E; Walker SL; Lema T; Aseffa A; Lockwood DN; Dockrell HM
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
[TBL] [Abstract][Full Text] [Related]
9. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V
Front Immunol; 2024; 15():1366125. PubMed ID: 38715615
[TBL] [Abstract][Full Text] [Related]
10. Involvement of TNF-Producing CD8
Silva PHL; Santos LN; Mendes MA; Nery JAC; Sarno EN; Esquenazi D
Am J Trop Med Hyg; 2019 Feb; 100(2):377-385. PubMed ID: 30652669
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.
Polycarpou A; Walker SL; Lockwood DN
Front Immunol; 2017; 8():233. PubMed ID: 28348555
[TBL] [Abstract][Full Text] [Related]
12. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
[TBL] [Abstract][Full Text] [Related]
13.
Tavares IF; Dos Santos JB; Pacheco FDS; Gandini M; Mariante RM; Rodrigues TF; Sales AM; Moraes MO; Sarno EN; Schmitz V
Front Med (Lausanne); 2021; 8():711623. PubMed ID: 34692720
[TBL] [Abstract][Full Text] [Related]
14. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
Modlin RL; Gebhard JF; Taylor CR; Rea TH
Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.
de Barros B; Lambert SM; Shah M; Pai VV; Darlong J; Rozario BJ; Alinda MD; Sales AM; Doni S; Hagge DA; Shrestha D; Listiawan MY; Yitaye AM; Nery JAC; Neupane KD; Dias VLA; Butlin CR; Nicholls PG; Lockwood D; Walker SL
BMJ Open; 2020 Nov; 10(11):e037700. PubMed ID: 33203627
[TBL] [Abstract][Full Text] [Related]
16. DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum.
Dias AA; Silva CO; Santos JP; Batista-Silva LR; Acosta CC; Fontes AN; Pinheiro RO; Lara FA; Machado AM; Nery JA; Sarno EN; Pereira GM; Pessolani MC
J Immunol; 2016 Sep; 197(5):1905-13. PubMed ID: 27474073
[TBL] [Abstract][Full Text] [Related]
17. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
18. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
19. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
[TBL] [Abstract][Full Text] [Related]
20. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
